An ethical case concerns a 16-year-old girl suffering from systemic scleroderma with a poor prognosis and her father's cultural beliefs, which do not allow for discussions about end-of-life care.
The AMA's Code of Medical Ethics is cited as the gold standard for issues surrounding informed consent by family members for procedures to be performed on the newly deceased.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.